Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma Review uri icon

Overview

MeSH Major

  • Carcinoma, Transitional Cell
  • Clinical Trials, Phase II as Topic
  • Patient Selection
  • Salvage Therapy
  • Urinary Bladder Neoplasms

publication date

  • January 2014

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.clgc.2014.03.016

PubMed ID

  • 25035282

Additional Document Info

start page

  • 395

end page

  • 8

volume

  • 12

number

  • 6